Drugs / PTCY
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06378060 Background | Mar 2024 → Apr 2026 overdue | aplastic anemia | Hematology department of the 920th hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PTCY | “aGVHD prophylaxis: PTCY 25mg/kg” NCT06378060 ↗ |